4.7 Review

Topical treatments for skin cancer

期刊

ADVANCED DRUG DELIVERY REVIEWS
卷 153, 期 -, 页码 54-64

出版社

ELSEVIER
DOI: 10.1016/j.addr.2019.11.002

关键词

Actinic keratosis; Basal cell carcinoma; Squamous cell carcinoma; Lentigo maligna; Melanoma; Topical therapy

资金

  1. National Health and Medical Research Council of Australia [APP1158283]
  2. Queensland State Government (Advance Queensland Industry Research Fellowships)

向作者/读者索取更多资源

Skin cancer is a broad term used to describe a number of different malignant indications of the skin. Skin cancers mostly comprise of the keratinocyte cancers [Basal Cell Carcinoma (BCC) and cutaneous Squamous Cell Carcinoma (SCC)], and melanoma. Surgical excision of these malignancies has been the preferred treatment of patients for decades. However, the decision to perform surgery can be affected by various considerations, including co-morbidities of the patient, the anatomical site of the lesion and potential intolerance for repeated excisions. Topical treatment of skin cancer may therefore be more appropriate in certain instances. Topical treatment potentially allows for higher drug levels at the tumor site, and may result in less overall toxicity than systemic agents. This review will specifically address the current agents used in topical treatment of skin cancers, and introduce emerging treatments from the natural product field that may also find utility in these indications. (c) 2019 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据